Federal Regulation of Unapproved Chelation Products

Federal approaches to the regulation of noncigarette tobacco products.

CONTEXT Under a grant funded by ClearWay Minnesota(SM) and in partnership with nationally recognized experts in tobacco product regulation, the Public Health Law Center investigated how laws at every level apply, or fail to apply, to noncigarette tobacco products--also called "other tobacco products." EVIDENCE ACQUISITION During the years 2010-2011, standard legal research techniques were use...

Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level?

Fetal experimentation and federal regulation.

Investigational new drugs: export requirements for unapproved new drug products. Final rule.

The Food and Drug Administration (FDA) is amending its regulations on the exportation of investigational new drugs, including biological products. The final rule describes four different mechanisms for exporting an investigational new drug product. These provisions implement changes in FDA's export authority resulting from the FDA Export Reform and Enhancement Act of 1996 and also simplify the ...

Political evolution of federal health care regulation.

Although federal regulation of health care faces cultural obstacles and skepticism among policymakers, it has grown markedly over the past two decades. Beginning in the 1970s with decentralized programs aimed at regulating provider behavior (Health Systems Agencies and certificate of need) and budgets (state rate setting), health care regulation grew more centralized in the 1980s as federal pol...